A single-component and hemi-hip prosthesis followed up for 43 years: A case report

• Published in: Medicine (Baltimore) 2019-02, Vol.98 (8), p.e14563-e14563
• Main Authors: Liu, Yuan, Chen, Hang-Jun, Zhang, Bin, Liu, Xu-Qiang, Xiao, Jun, Cheng, Cheng-Kung, Dai, Min
• Format: Article
• Language: English
• Subjects: Adult; Aftercare - methods; Arthroplasty, Replacement, Hip - instrumentation; Arthroplasty, Replacement, Hip - methods; Bone Neoplasms - diagnosis; Bone Neoplasms - surgery; Clinical Case Report; Giant Cell Tumor of Bone - diagnosis; Giant Cell Tumor of Bone - surgery; Hemiarthroplasty - instrumentation; Hemiarthroplasty - methods; Hip Joint - pathology; Hip Joint - surgery; Hip Prosthesis - adverse effects; Humans; Male
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000014563

Giant cell tumor (GCT) is a locally aggressive bone tumor with a high recurrence rate if not completely excised. And reconstructive hip surgery using an artificial prosthesis in a young active patient is controversial because of problems related to the durability of the artificial joint. A 30-year-old man presented with right hip pain and other more severe symptoms, but without fever or night sweats. After 4 months, he experienced intense pain at the root of the right leg and limitation of motion after falling from a bicycle. Giant cell tumor. The patient was treated with surgical resection of the total tumor, and hemiarthroplasty of the hip joint using a custom-made titanium femoral prosthesis. The patient could perform activities of daily living, even walking long distance without pain. He continued to work as a teacher for 30 years and retired 11 years after the surgery. A well-designed, custom-fitted, single-component, wear-resistant joint prosthesis should be the brand-new direction of development of artificial joints.